The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) and Bloomberg BNA were pleased to present “TSCA Confidential Business Information and Generic Naming: Analyzing the New Rules,” the fourth webinar in the 2018 Chemical Policy Summit Series. Protecting confidential business information (CBI), including chemical identity, has never been easy but remains an essential component of a successful commercial chemical strategy. New Toxic Substances Control Act (TSCA) Section 14 is much more prescriptive about what can and cannot be protected and what submitters must do to substantiate CBI to withstand scrutiny. This complimentary, hour-long webinar focused on what’s new, what’s not, and how best strategically to create generic names to protect specific chemical substance identity. Tracy C. Williamson, Ph.D., Chief, Industrial Chemistry Branch, EPA; Scott M. Sherlock, Attorney Advisor, EPA; and Richard E. Engler, Ph.D., Director of Chemistry, Acta, presented.